Research Analysts Issue Forecasts for KYMR Q1 Earnings
Kymera Therapeutics, Inc. (NASDAQ:KYMR – Free Report) – Equities researchers at B. Riley issued their Q1 2025 EPS estimates for shares of Kymera Therapeutics in a research report issued to clients and investors on Monday, March 3rd. B. Riley analyst K. Patel anticipates that the company will post earnings of ($0.94) per share for the […]
Kymera Therapeutics, Inc. (NASDAQ:KYMR – Free Report) – Equities researchers at B. Riley issued their Q1 2025 EPS estimates for shares of Kymera Therapeutics in a research report issued to clients and investors on Monday, March 3rd. B. Riley analyst K. Patel anticipates that the company will post earnings of ($0.94) per share for the […]
